386 related articles for article (PubMed ID: 22329482)
1. The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patients.
Ra HS; Shin SJ; Kim JH; Lim H; Cho BC; Roh MR
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e53-9. PubMed ID: 22329482
[TBL] [Abstract][Full Text] [Related]
2. The impact of skin disease following renal transplantation on quality of life.
Moloney FJ; Keane S; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2005 Sep; 153(3):574-8. PubMed ID: 16120145
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors.
Osio A; Mateus C; Soria JC; Massard C; Malka D; Boige V; Besse B; Robert C
Br J Dermatol; 2009 Sep; 161(3):515-21. PubMed ID: 19466958
[TBL] [Abstract][Full Text] [Related]
4. Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life.
Joshi SS; Ortiz S; Witherspoon JN; Rademaker A; West DP; Anderson R; Rosenbaum SE; Lacouture ME
Cancer; 2010 Aug; 116(16):3916-23. PubMed ID: 20564072
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
6. Quality of life assessment in nonmelanoma cervicofacial skin cancer.
Rhee JS; Loberiza FR; Matthews BA; Neuburg M; Smith TL; Burzynski M
Laryngoscope; 2003 Feb; 113(2):215-20. PubMed ID: 12567071
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in patients with colorectal cancer who receive oral uracil and tegafur plus leucovorin.
Tsunoda A; Nakao K; Watanabe M; Matsui N; Tsunoda Y
Jpn J Clin Oncol; 2010 May; 40(5):412-9. PubMed ID: 20085907
[TBL] [Abstract][Full Text] [Related]
8. Treatment of metastatic colorectal cancer with cetuximab: influence on the quality of life.
Unger K; Niehammer U; Hahn A; Goerdt S; Schumann M; Thum S; Schepp W
Z Gastroenterol; 2013 Aug; 51(8):733-9. PubMed ID: 23955138
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and sun-protective behavior in patients with skin cancer.
Rhee JS; Matthews BA; Neuburg M; Smith TL; Burzynski M; Nattinger AB
Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):141-6. PubMed ID: 14967741
[TBL] [Abstract][Full Text] [Related]
10. Quality of life assessment among patients with peristomal skin disease.
Nybaek H; Knudsen DB; Laursen TN; Karlsmark T; Jemec GB
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):139-43. PubMed ID: 19918185
[TBL] [Abstract][Full Text] [Related]
11. Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer.
Lacouture ME; Mitchell EP; Piperdi B; Pillai MV; Shearer H; Iannotti N; Xu F; Yassine M
J Clin Oncol; 2010 Mar; 28(8):1351-7. PubMed ID: 20142600
[TBL] [Abstract][Full Text] [Related]
12. Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients.
Mühleisen B; Büchi S; Schmidhauser S; Jenewein J; French LE; Hofbauer GF
Arch Dermatol; 2009 Jul; 145(7):774-80. PubMed ID: 19620558
[TBL] [Abstract][Full Text] [Related]
13. Quality of life instrument for Turkish people with skin diseases.
Gurel MS; Yanik M; Simsek Z; Kati M; Karaman A
Int J Dermatol; 2005 Nov; 44(11):933-8. PubMed ID: 16336527
[TBL] [Abstract][Full Text] [Related]
14. [Impact of cutaneous toxicities associated with targeted therapies on quality of life. Results of a longitudinal exploratory study].
Charles C; Sultan S; Bungener C; Mateus C; Lanoy E; Dauchy S; Verschoore M; Robert C
Bull Cancer; 2013 Mar; 100(3):213-22. PubMed ID: 23501241
[TBL] [Abstract][Full Text] [Related]
15. Does enough quality of life-related discussion occur during dermatology outpatient consultations?
David SE; Ahmed Z; Salek MS; Finlay AY
Br J Dermatol; 2005 Nov; 153(5):997-1000. PubMed ID: 16225613
[TBL] [Abstract][Full Text] [Related]
16. Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer.
Bouché O; Ben Abdelghani M; Labourey JL; Triby S; Bensadoun RJ; Jouary T; Des Guetz G
World J Gastroenterol; 2019 Aug; 25(29):4007-4018. PubMed ID: 31413534
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life.
Holme SA; Anstey AV; Finlay AY; Elder GH; Badminton MN
Br J Dermatol; 2006 Sep; 155(3):574-81. PubMed ID: 16911284
[TBL] [Abstract][Full Text] [Related]
18. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013
[TBL] [Abstract][Full Text] [Related]
19. [European Organization for Research and Treatment of Cancer QLQ-C30 and functional assessment of cancer therapy- general for measurement of quality of life in colorectal cancer patients who received adjuvant chemotherapy- a comparison].
Tsunoda A
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1719-24. PubMed ID: 20841934
[TBL] [Abstract][Full Text] [Related]
20. An assessment of the quality of life in older patients with skin disease.
Shah M; Coates M
Br J Dermatol; 2006 Jan; 154(1):150-3. PubMed ID: 16403109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
